A brief response to Sealey and Laragh

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 8, Issue 2, 2007, Pages 53-

  Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Allskiren; Angiotensin converting enzyme inhibitors; Renin inhibition

Indexed keywords

ALISKIREN; ANGIOTENSIN II; RENIN;

CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; NOTE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; UNSPECIFIED SIDE EFFECT;

AMIDES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FUMARATES; HUMANS; HYPERTENSION; RENIN;

EID: 34547971845     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2007.020     Document Type: Note

References (1)

1. Sealey JE, Laragh JH. Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. AJH 2007;20:587-97.